# Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy

> **NCT06524570** · PHASE1 · RECRUITING · sponsor: **UMC Utrecht** · enrollment: 24 (estimated)

## Conditions studied

- Cancer
- Metastatic Cancer

## Interventions

- **DEVICE:** HIFU-HT
- **DRUG:** ICI

## Key facts

- **NCT ID:** NCT06524570
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-26
- **Primary completion:** 2030-08-01
- **Final completion:** 2030-08-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06524570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06524570, "Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06524570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*